Bicycle Therapeutics (BCYC) Accumulated Depreciation (2018 - 2024)
Historic Accumulated Depreciation for Bicycle Therapeutics (BCYC) over the last 7 years, with Q2 2024 value amounting to $16.6 million.
- Bicycle Therapeutics' Accumulated Depreciation rose 5903.08% to $16.6 million in Q2 2024 from the same period last year, while for Jun 2024 it was $16.6 million, marking a year-over-year increase of 5903.08%. This contributed to the annual value of $13.4 million for FY2023, which is 7032.94% up from last year.
- Bicycle Therapeutics' Accumulated Depreciation amounted to $16.6 million in Q2 2024, which was up 5903.08% from $14.9 million recorded in Q1 2024.
- In the past 5 years, Bicycle Therapeutics' Accumulated Depreciation registered a high of $16.6 million during Q2 2024, and its lowest value of $2.8 million during Q1 2020.
- In the last 5 years, Bicycle Therapeutics' Accumulated Depreciation had a median value of $5.1 million in 2022 and averaged $7.3 million.
- Its Accumulated Depreciation has fluctuated over the past 5 years, first skyrocketed by 1508.55% in 2022, then skyrocketed by 10158.3% in 2023.
- Bicycle Therapeutics' Accumulated Depreciation (Quarter) stood at $4.0 million in 2020, then rose by 19.05% to $4.8 million in 2021, then skyrocketed by 63.81% to $7.9 million in 2022, then surged by 70.33% to $13.4 million in 2023, then grew by 23.99% to $16.6 million in 2024.
- Its Accumulated Depreciation stands at $16.6 million for Q2 2024, versus $14.9 million for Q1 2024 and $13.4 million for Q4 2023.